Group items matching

in title, tags, annotations or url

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing to apply behavioral economics principles to build interventions into electronic health records (EHRs) for the purpose of improving physician compliance with recommended treatment guidelines, thereby improving quality of care, health outcomes and reducing health disparities.  This FOA will support pilot research to test the feasibility of implementing and integrating EHR-based behavioral economics interventions (R21 phase) that, if successful, can transition to an R33 phase for implementation of large pragmatic trials.  

The U.S. Environmental Protection Agency (EPA), through its Science to Achieve Results (STAR) program, seeks applications for research on how pollution affects human health in the context of the total environment - built, natural, and social environments interacting together with inherent characteristics and interactions. Proposed research should develop and test innovative models or impact assessment approaches to examine causal relationships of chemical pollutants and health effects with modifying interactions among the variables representing all of the major stressors and factors involved in a person's life. Proposals that integrate a diverse field of disciplines (social science, economics, epidemiology, engineering, environmental science, biology, statistics, toxicology, chemistry, etc.) to address the complexity of the total environment research problem are highly recommended.

The Centers of Excellence on Environmental Health Disparities (EHD) research program is a collaborative effort supported by the National Institute on Minority Health and Health Disparities (NIMHD), the National Institute of Environmental Health Sciences (NIEHS), and the U.S. Environmental Protection Agency (EPA) that encourages basic, biological, clinical, epidemiological, behavioral and/or social scientific investigations of disease conditions that are known to be a significant burden in low socioeconomic and health disparate populations. The centers define environmental health disparities as inequities in illnesses that are mediated by disproportionate exposures associated with the social, natural and built environments. The kick-off meeting will feature presentations from each of the five funded centers highlighting their proposed research.

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental grant (R21) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this PA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development. 

The Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and socio-ecological principles and processes that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; or the cultural, social, behavioral, and economic dimensions of disease transmission. Research may be on zoonotic, environmentally-borne, vector-borne, or enteric diseases of either terrestrial or freshwater systems and organisms, including diseases of animals and plants, at any scale from specific pathogens to inclusive environmental systems. Proposals for research on disease systems of public health concern to developing countries are strongly encouraged, as are disease systems of concern in agricultural systems. Investigators are encouraged to involve the public health research community, including for example, epidemiologists, physicians, veterinarians, food scientists, social scientists, entomologists, pathologists, virologists, or parasitologists with the goal of integrating knowledge across disciplines to enhance our ability to predict and control infectious diseases.

The Small Business Innovation Research (SBIR) Program stimulates technological innovation in the private sector by strengthening the role of small business concerns in meeting Federal research and development needs, increasing the commercial application of federally supported research results, and fostering and encouraging participation by socially and economically disadvantaged and women-owned small businesses. The topics, listed below, are detailed on the SBIR/STTR topics homepage: Educational Technologies and Applications (EA) Information and Communication Technologies (IC) Semiconductors (S) and Photonic (PH) Devices and Materials Electronic Hardware, Robotics and Wireless Technologies (EW) Advanced Manufacturing and Nanotechnology (MN) Advanced Materials and Instrumentation (MI) Chemical and Environmental Technologies (CT) Biological Technologies (BT) Smart Health (SH) and Biomedical (BM) Technologies

The Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and socio-ecological principles and processes that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; or the cultural, social, behavioral, and economic dimensions of disease transmission. Research may be on zoonotic, environmentally-borne, vector-borne, or enteric diseases of either terrestrial or freshwater systems and organisms, including diseases of animals and plants, at any scale from specific pathogens to inclusive environmental systems. Proposals for research on disease systems of public health concern to developing countries are strongly encouraged, as are disease systems of concern in agricultural systems. Investigators are encouraged to involve the public health research community, including for example, epidemiologists, physicians, veterinarians, food scientists, social scientists, entomologists, pathologists, virologists, or parasitologists with the goal of integrating knowledge across disciplines to enhance our ability to predict and control infectious diseases.

This Funding Opportunity Announcement (FOA) encourages Small Research Grant (R03) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this PA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development.

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental grant (R21) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this PA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development.

This Funding Opportunity Announcement (FOA) encourages exploratory/developmental grant (R21) applications from institutions and organizations that propose to study the effects and functional consequences of cannabis and cannabinoid exposures on the developing brain, from pre-, peri-, post-natal development through young adulthood in animal models and humans. Topics of interest pertaining to this PA include, but are not limited to: molecular and cellular mechanisms of cannabis/cannabinoid effects on the developing brain; long term functional consequences of cannabis/cannabinoid exposure on learning and memory, cognitive and emotional development.

EPA and NIEHS present the NIEHS/EPA Children's Centers Webinar Series: Protecting Children's Health for a Lifetime. The webinar is co-sponsored by the National Center for Environmental Research and the Office of Children's Health Protection. The topic of the January 2016 webinar is Childhood Obesity.

The purpose of this Notice of Funding Opportunity (NOFO) is to expand the vision and eye health surveillance system by identifying and incorporating new data sources and validating data and key indicators, maintaining the existing system, and promoting the vision and eye health surveillance system to stakeholders to monitor the burden of vision loss and eye diseases and ultimately to improve the vision and eye health of the nation. Vision loss is recognized as a public health problem because it affects more than 4 million people aged 40 years and older in the United States. It is associated with higher prevalence of multiple chronic conditions such as diabetes, cardiovascular health, falls, injuries, depression, smoking, premature mortality and overall poorer quality of life. The United States government in Healthy People 2010 and 2020, in conjunction with the vision and eye care communities, have identified the reduction of population disparities in vision loss and access to eye care services as top public health priorities. Despite the knowledge about the individual and societal burden of vision loss and eye diseases, the public health surveillance system in the United States has only just begun to systematically understand and monitor the magnitude and implications of vision loss, access to eye care, and effectiveness of services that potentially improve health and quality of life of those who are at risk of or experience vision loss.

Funding opportunities include: Open Study/Research Awards English Teaching Assistant Awards Fulbright-Fogarty Awards in Public Health Fulbright-National Geographic Digital Storytelling Fellowship Critical Language Enhancement Award

This initiative will fund the dissemination and implementation of clinical and organizational patient-centered outcomes research (PCOR) findings into primary care practice to improve the delivery of patient-centered approaches to identifying and managing

Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.

Supported by the NIH Common Fund (Common Fund) Science of Behavior Change (SOBC) Program, this Funding Opportunity Announcement (FOA) solicits exploratory and developmental research project applications (R21) that will further the goal of the SOBC Program to advance a mechanisms-focused, experimental medicine approach to behavior change research. Funded projects in the SOBC Research Network have developed experimental manipulations, assays, and/or measures (hereafter referred to as assays for brevity) to support an experimental medicine approach to behavior change research. The SOBC Measures Repository assays are accessible from the SOBC Research Network Open Science Framework (OSF) page at https://osf.io/zp7b4. The goal of this announcement is to leverage SOBC Measures Repository assays of putative targets in self-regulation, stress reactivity and stress resilience, and interpersonal and social processes domains to (1) engage a selected putative target(s)/mechanism(s) of action or verify target engagement of the selected target(s)/mechanism(s) of action, and (2) test the degree to which engaging the putative target(s)/mechanism(s) of action produces a short-term desired change in a health behavior. Putative targets are the mechanisms or processes hypothesized to be malleable and play a causal role in producing behavior change, including medical regimen adherence.

The purpose of this funding opportunity announcement (FOA) is to support research to develop and qualify a Patient Reported Outcome (PRO) for Non-Cystic Fibrosis Bronchiectasis (NCFB) under FDA's Drug Development Tools Qualification Program. This would include the qualitative phase of developing the instrument, quantitative phase of testing the instrument, and qualification of the instrument. It is expected that this qualified PRO would help improve upon the current design, conduct, and interpretation of anti-infective clinical trials in NCFB patients, for which optimal endpoints are currently lacking. This work directly aligns with FDA's research area of interest to "stimulate innovation in clinical evaluations and personalized medicine to improve product performance and patient outcomes.  

The mission of the American Association on Health and Disability is to contribute to national, state, and local efforts to promote health and wellness in people with disabilities and identify effective intervention strategies that reduce health disparities between people with disabilities and the general population. AAHD accomplishes its mission through research, education, and advocacy at the national, state, and community levels. To that end, the AAHD Frederick J. Krause Scholarship on Health and Disability is awarded annually to deserving students with a disability who are pursuing undergraduate/graduate studies (at least a sophomore in college) at an accredited university in an area related to health and disability, including but not limited to public health, health promotion, disability studies, disability research, rehabilitation engineering, audiology, disability policy, special education, or other majors that impact quality of life for persons with disabilities. Scholarships of up to $1,000 will be awarded in late January/early February 2019. To be eligible, applicants must be enrolled full time as an undergraduate (freshman or beyond) or part or full time in graduate school, have a documented disability, and be able provide documentation of their disability. (Applicants who have not yet graduated from high school will not be considered.) In addition, applicants must be a citizen or legal resident of the United States enrolled in an accredited U.S. university. Preference will be given to students majoring in public health, disability studies, disability research, health promotion, or a field related to disability and health.

EPA's P3 - People, Prosperity and the Planet - Program is a unique competition that is open to teams of college/university students working to design solutions for a sustainable future. P3 offers students hands-on experience that brings their classroom learning to life, while also allowing them to create tangible changes in their communities. This annual, two-phased research grants program challenges students to research, develop, and design innovative projects that address real world challenges involving all areas of environmental protection and public health. Phase I serves as a "proof of concept," where teams are awarded a one-year grant of up to $25,000 to develop their idea and showcase their research in the spring at EPA's National Student Design Expo (NSDE). These teams are then eligible to compete for a Phase II grant of up to $100,000 to implement their design in a real world setting. P3 aims to foster progress towards environmental awareness by achieving the symbiotic goals of improved quality of life for all people, economic prosperity, and protection of the planet - people, prosperity and the planet.

This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients.